Cartherics has a strong research team experienced in immunology, stem cell and cancer biology, product development, animal cancer models, patenting, product development and commercialisation. The research team generates the new ideas and brings these to proof of principle, the translation team generates the preclinical data, and the development team develops the products for clinical trial. Products are progressed in the product pipeline based on careful assessment of the intellectual property (IP) environment, generation of new IP and/or negotiating rights to third party IP, assessment of efficacy in animal models and evaluation of the clinical need.